A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve

NANot yet recruitingINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2029

Conditions
Aortic Valve DiseaseCardiovascular Diseases
Interventions
DEVICE

Venus-Neo Surgical Aortic Valve

Implant of a Venus-Neo Surgical Aortic Valve

Trial Locations (1)

13353

Deutsches Herzzentrum Berlin-Charité, Berlin

All Listed Sponsors
lead

Jilin Venus Haoyue Medtech Limited

INDUSTRY